Branchiootorenal syndrome |
EYA1
|
Loss of function mutations |
[87, 95] |
Otofaciocervical syndrome |
EYA1
|
Loss of function mutations |
[97] |
Cardiofacial syndrome |
EYA1
|
Loss of function mutations |
[107] |
Congenital cataract |
EYA1
|
Loss of function mutations |
[47] |
Wilms’ tumor |
EYA1
|
Overexpression |
[137] |
EBV-negative gastric cancer |
EYA1
|
Frequent methylation |
[138] |
Late-onset deafness |
EYA4
|
Loss of function mutations |
[99] |
Dilated cardiomyopathy |
EYA4
|
Deletion |
[106] |
Esophageal adenocarcinoma |
EYA4
|
Frequent methylation (overexpression) |
[128] |
Colon cancer |
EYA4
|
Overexpression |
[130] |
Colorectal cancer |
EYA4
|
Overexpression |
[131] |
Colorectal cancer |
EYA2
|
Silencing methylation |
[139] |
Epithelial ovarian cancer |
EYA2
|
Overexpression |
[133] |
Lung adenocarcinoma |
EYA2
|
Overexpression |
[134] |
Pancreatic ductal adenocarcinoma |
EYA3
|
Frequent deletion |
[140] |